D W Paty

发表

Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluation

A J Petkau, S L Sacks, D. Li, 1990, Neurology.

Magnetic Resonance Imaging in the Assessment of Disease Activity in Multiple Sclerosis

D. Paty, D W Paty, 1988, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Scales for rating impairment in multiple sclerosis

D. Paty, E. Willoughby, D W Paty, 1988, Neurology.

PRISMS-4: Long-term efficacy of interferon-&bgr;-1a in relapsing MS

Richard A. C. Hughes, H P Hartung, F Barkhof, 2001, Neurology.

Cause of death in patients attending multiple sclerosis clinics

D. Paty, A. Sadovnick, G. Ebers, 1991, Neurology.

Effect of interferon beta-1b in MS: assessment of annual accumulation of PD/T2 activity on MRI. UBC MS/MRI Analysis Group and the MS Study Group.

D. Li, D. Paty, G. Zhao, 2000, Neurology.

Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis.

D. Li, D. Paty, D K Li, 1999, Annals of neurology.

Magnetic resonance techniques to monitor the long term evolution of multiple sclerosis pathology and to monitor definitive clinical trials.

D. Paty, H. McFarland, D W Paty, 1998, Journal of neurology, neurosurgery, and psychiatry.

Neuroimaging in multiple sclerosis.

D. Paty, J. Noseworthy, G. Ebers, 1984, Neurologic clinics.

Magnetic resonance in multiple sclerosis.

D. Paty, D W Paty, 1997, Current opinion in neurology and neurosurgery.